Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shibin Cheng has a total of 67 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Revised Two-Stage Model of Preeclampsia Based on Autophagic Dysfunction: A Comprehensive Review

    by Atsushi Furuta, Tomoko Shima, Takashi Nishigori, Kiyotaka Yamada, Haruka Nunomura, Mihoko Yoshida, Shina Sakaguchi, Takuya Majima, Akemi Yamaki-Ushijima, Kanto Shozu, et al.

    A revised two-stage model of preeclampsia is proposed, centering on an autophagy-dependent requirement for extravillous trophoblast entry into the proximal one-third of the myometrium. The One-Third Myometrium Enigma, introduced here, denotes the unresolved physiological rule that early placentation requires trophoblasts to traverse decidua and reach the proximal one-third of myometrium under hypoxia and nutrient scarcity. The hypothesis posits a timed rise in basal autophagy to sustain trophoblast energy homeostasis and invasion, accompanied by TFEB-driven lysosomal programs that enable villous cytotrophoblast syncytialization. Autophagic dysfunction could contribute to shallow invasion, chronic placental hypoxia, fetal growth restriction, and release of placental injury signals preceding maternal syndrome. Potential failure modes include reduced autophagic flux due to inhibition of autophagosome to lysosome fusion or mistimed persistence of hypoxia signaling, such as prolonged HIF-1α activity. Collectively, this evidence suggests that impaired autophagy is a testable contributor to preeclampsia pathogenesis. Predictions include early risk stratification with circulating autophagy markers and extracellular vesicle microRNAs, and therapeutic benefit from autophagy modulation that targets AMPK or mTOR or activates TFEB with safety constraints. This framework reframes preeclampsia as a disorder of placental quality control and specifies where and when autophagy may be required.


  • Evidence for Complement Activation in Preeclampsia Placenta and Its Presence in Circulation

    by Shibin Cheng, Wendy Norris, Satyan Kalkunte, Sukanta Jash, Lauren R. Richardson, Surendra Sharma

    Problem: Preeclampsia (PE) is a severe pregnancy disorder caused by a multitude of dysregulated events, including placental insufficiency, inflammation, anti‐angiogenic factors, and cellular stress signals. Inflammatory activation of the complement cascade has also been thought to be a contributory factor to PE pathophysiology. However, the placental and circulating presence of activated complement factors and their precise impact on gestational age‐dependent trophoblast health remain inadequately addressed.Method of Study: Complement activation was assessed in placental tissue samples from women with normal pregnancy (NP) and PE. Immunofluorescent staining was employed to detect the membrane attack complex (MAC) deposition in placental tissues. This approach was also used in placenta‐derived human extravillous trophoblast cells derived from the third trimester (TCL1) and first trimester (HTR‐8) and term primary human cytotrophoblasts. Dual staining with Propidium Iodide (PI) and annexin V antibody was conducted to assess cell viability in TCL‐1 cells, HTR‐8 cells, and freshly isolated term primary human trophoblasts when exposed to serum samples from NP (NPS), PE (PES), and PES after complement inactivation by heating, heparin treatment, or blockade with antibodies. The expression levels of complement regulatory proteins, specifically decay‐accelerating factor (CD55), protectin (CD59), and membrane cofactor protein (CD46), on trophoblasts were quantified using Fluorescence‐activated cell sorting and immunohistochemistry.Results: Substantial MAC deposition and a notable reduction in CD55 expression in the PE placenta compared to that from NP was observed, indicating heightened complement activation and impaired complement regulation in PE. Exposure to a significant subpopulation of PES (41%, n = 41) induced cell death exclusively in TCL‐1 cells, not in HTR‐8 cells and primary human trophoblasts. Remarkably, complement inactivation in PES abolished MAC deposition and rescued TCL‐1 cells from death, unequivocally implicating complement activity in trophoblast cell demise. Flow cytometry analysis disclosed lower levels of CD55 and CD59 expression in TCL‐1 cells in contrast to HTR‐8 cells and primary human trophoblasts. Blockade of CD55 and CD59 in HTR‐8 cells enhanced their susceptibility to PES‐induced cell death.Conclusions: These findings underscore the significance of amplified complement activation, compromised complement inhibitory regulation, and consequent trophoblast cell death as potential contributors to the pathogenesis of PE. Strategies targeting dysregulated complement activity offer promising avenues for novel therapeutic interventions in PE management.


  • Open Access

    Novel Role of Pin1-Cis P-Tau-ApoE Axis in the Pathogenesis of Preeclampsia and Its Connection with Dementia

    by Emmanuel Amabebe, Zheping Huang, Sukanta Jash, Balaji Krishnan, Shibin Cheng, Akitoshi Nakashima, Yitong Li, Zhixong Li, Ruizhi Wang, Ramkumar Menon, et al.

    Preeclampsia (preE) is a severe multisystem hypertensive syndrome of pregnancy associated with ischemia/hypoxia, angiogenic imbalance, apolipoprotein E (ApoE)-mediated dyslipidemia, placental insufficiency, and inflammation at the maternal–fetal interface. Our recent data further suggest that preE is associated with impaired autophagy, vascular dysfunction, and proteinopathy/tauopathy disorder, similar to neurodegenerative diseases such as Alzheimer’s disease (AD), including the presence of the cis stereo-isoform of phosphorylated tau (cis P-tau), amyloid-β, and transthyretin in the placenta and circulation. This review provides an overview of the factors that may lead to the induction and accumulation of cis P-tau-like proteins by focusing on the inactivation of peptidyl-prolyl cis–trans isomerase (Pin1) that catalyzes the cis to trans isomerization of P-tau. We also highlighted the novel role of the Pin1-cis P-tau-ApoE axis in the development of preE, and propagation of cis P-tau-mediated abnormal protein aggregation (tauopathy) from the placenta to cerebral tissues later in life, leading to neurodegenerative conditions. In the case of preE, proteinopathy/tauopathy may interrupt trophoblast differentiation and induce cell death, similar to the events occurring in neurons. These events may eventually damage the endothelium and cause systemic features of disorders such as preE. Despite impressive research and therapeutic advances in both fields of preE and neurodegenerative diseases, further investigation of Pin1-cis P-tau and ApoE-related mechanistic underpinnings may unravel novel therapeutic options, and new transcriptional and proteomic markers. This review will also cover genetic polymorphisms in the ApoE alleles leading to dyslipidemia induction that may regulate the pathways causing preE or dementia-like features in the reproductive age or later in life, respectively.


  • Open Access

    Editorial: Autophagy: unveiling the mechanisms and implications in health and disease

    by Shibin Cheng, Xiaodi Chen, Aihua Liao

    Autophagy, a vital cellular process responsible for maintaining homeostasis by degrading and recycling cellular components, has emerged as a critical area of research in recent years (1)(2)(3)(4)(5). This intricate mechanism plays a dual role in health and disease, safeguarding cellular function while also contributing to the pathology of various conditions. This special issue explores the complexities of autophagy, shedding light on its diverse roles across a spectrum of diseases, including chronic obstructive pulmonary disease (COPD), rotator cuff injuries, bile duct carcinoma, and Alzheimer's disease. The featured studies provide fresh insights into the protective and potentially harmful aspects of autophagy, offering new avenues for therapeutic intervention and advancing our understanding of its role in disease progression.In the intricate web of cellular homeostasis, autophagy and oxidative stress are two fundamental players that maintain equilibrium. COPD is a progressive respiratory condition characterized by persistent inflammation and oxidative stress, leading to irreversible airflow limitation (6). In this review, Zhao et al. (Front Physiol. 2022 Sep 26;13:1004275) illuminated the nuanced interplay between these processes and their roles in COPD pathogenesis. Oxidative stress results from an imbalance between reactive oxygen species (ROS) and the body's ability to detoxify them, leading to cellular damage and inflammation. Autophagy, a cellular process responsible for degrading and recycling damaged organelles and proteins, plays a dual role in COPD. On one hand, autophagy helps mitigate oxidative stress by removing damaged mitochondria, which are significant sources of ROS. On the other hand, chronic oxidative stress can impair autophagic processes, leading to the accumulation of damaged cellular components. This disruption contributes to the progression of COPD by promoting inflammation and cellular senescence. Recent insights into this interplay underscore the potential of targeting autophagy pathways as a therapeutic strategy to mitigate oxidative stress and improve outcomes in COPD patients.Rotator cuff injuries, particularly chronic enthesis tears, pose significant challenges in orthopedic medicine. Enthesis refers to the site where tendons or ligaments attach to bone, and tears at these sites can lead to debilitating pain and functional impairment. The pathology of these injuries is increasingly recognized to involve oxidative stress and autophagy (7). Oxidative stress in rotator cuff tears results from the excessive production of ROS and impaired antioxidant defenses. This imbalance damages cellular components and contributes to inflammation and tissue degeneration. Autophagy in this context appears to be a double-edged sword. While autophagy can help remove damaged cells and repair tissues, excessive or dysregulated autophagy may exacerbate tissue damage and inflammation. The challenge in treating chronic rotator cuff tears lies in modulating autophagy to promote healing while minimizing oxidative stress-induced damage. Additionally, the study examined autophagy's role in chemoresistance in breast cancer. It was found that dihydroartemisinin and artesunate could reverse doxorubicin resistance by inducing autophagy, as indicated by increased levels of LC3B and ATG7. This research highlights the intricate role of autophagy in cancer and its potential as a therapeutic target for improving treatment outcomes and overcoming drug resistance.Barmaki et al. (Frontiers in Aging Neuroscience, November 2023) reviewed the critical role of autophagy dysfunction in Alzheimer's disease (AD). Autophagy, a key cellular process for maintaining protein balance and organelle health, is disrupted in AD, leading to the accumulation of amyloid-beta plaques, tau tangles, and damaged organelles-core features of the disease.The review emphasizes the complex interactions between autophagy and other cellular systems, such as mitochondrial function and endoplasmic reticulum stress. Dysfunction in these interconnected pathways further exacerbates the progression of AD. For instance, impaired autophagy can contribute to mitochondrial dysfunction, increasing oxidative stress and cellular damage. Effective AD therapies may need to address these related systems alongside autophagy.Genetic and environmental factors influencing autophagy also impact AD susceptibility.Variations in genes encoding autophagic proteins have been linked to an increased risk of the disease, suggesting that understanding these genetic factors could help in identifying at-risk individuals and tailoring preventative strategies.Recent advances in autophagy-modulating drugs show potential for AD treatment by enhancing protein clearance and reducing neurotoxic aggregates in preclinical models. However, translating these findings into clinical practice requires careful evaluation of drug dosing, safety, and long-term efficacy. The study advocates for continued research and clinical trials to optimize autophagy-based therapies for AD.Overall, targeting autophagy mechanisms holds promise for developing new therapeutic strategies to slow or potentially halt the progression of Alzheimer's disease.The papers in this special issue explore the critical role of autophagy in COPD, rotator cuff injuries, bile duct carcinoma, and Alzheimer's disease, highlighting its dual nature as both a protector and potential contributor to disease. While these studies provide valuable insights, they represent just a fraction of the broader spectrum of conditions in which autophagy dysregulation plays a key role, including adverse pregnancy outcomes, renal and cardiovascular diseases, diabetes, and obesity (1)(2)(3)(4)(5). The intricate balance of autophagic activity is essential for maintaining health. As we gain a deeper understanding of autophagy's multifaceted roles, new therapeutic avenues are emerging, offering hope for more effective treatments...


  • Open Access

    Cis P-tau is a central circulating and placental etiologic driver and therapeutic target of preeclampsia

    by Sukanta Jash, Sayani Banerjee, Shibin Cheng, Bin Wang, Chenxi Qiu, Asami Kondo, Jan Ernerudh, Xiao Zhen Zhou, Kun Ping Lu, Surendra Sharma

    Preeclampsia (PE) is the leading cause of maternal and fetal mortality globally and may trigger dementia later in life in mothers and their offspring. However, the etiological drivers remain elusive. Cis P-tau is an early etiological driver and blood biomarker in pre-clinical Alzheimer’s and after vascular or traumatic brain injury, which can be targeted by stereo-specific antibody, with clinical trials ongoing. Here we find significant cis P-tau in the placenta and serum of PE patients, and in primary human trophoblasts exposed to hypoxia or sera from PE patients due to Pin1 inactivation. Depletion of cis P-tau from PE patient sera by the antibody prevents their ability to disrupt trophoblast invasion and endovascular activity and to cause the PE-like pathological and clinical features in pregnant humanized tau mice. Our studies uncover that cis P-tau is a central circulating etiological driver and its stereo-specific antibody is valuable for early PE diagnosis and treatment.


  • Open Access

    Gestational Age-Dependent Regulation of Transthyretin in Mice during Pregnancy

    by Shibin Cheng, Zheping Huang, Akitoshi Nakashima, Surendra Sharma

    Our prior studies have shown that protein misfolding and aggregation in the placenta are linked to the development of preeclampsia, a severe pregnancy complication. We identified transthyretin (TTR) as a key component of the aggregated protein complex. However, the regulation of native TTR in normal pregnancy remains unclear. In this study, we found that pregnant mice exhibited a remarkable and progressive decline in serum TTR levels through gestational day (gd) 12–14, followed by an increase in late pregnancy and postpartum. Meanwhile, serum albumin levels showed a modest but statistically significant increase throughout gestation. TTR protein and mRNA levels in the liver, a primary source of circulating TTR, mirrored the changes observed in serum TTR levels during gestation. Intriguingly, a similar pattern of TTR alteration was also observed in the serum of pregnant women and pregnant interleukin-10-knockout (IL-10−/−) mice with high inflammation background. In non-pregnant IL-10−/− mice, serum TTR levels were significantly lower than those in age-matched wild-type mice. Administration of IL-10 to non-pregnant IL-10−/− mice restored their serum TTR levels. Notably, dysregulation of TTR resulted in fewer implantation units, lower fetal weight, and smaller litter sizes in human TTR-overexpressing transgenic mice. Thus, TTR may play a pivotal role as a crucial regulator in normal pregnancy, and inflammation during pregnancy may contribute to the downregulation of serum TTR presence.


  • Open Access

    The Role of Autophagy in the Female Reproduction System: For Beginners to Experts in This Field

    by Akitoshi Nakashima, Atsushi Furuta, Kiyotaka Yamada, Mihoko Yoshida-Kawaguchi, Akemi Yamaki-Ushijima, Ippei Yasuda, Masami Ito, Satoshi Yamashita, Sayaka Tsuda, Satoshi Yoneda, et al.

    Autophagy is a fundamental process involved in regulating cellular homeostasis. Autophagy has been classically discovered as a cellular process that degrades cytoplasmic components non-selectively to produce energy. Over the past few decades, this process has been shown to work in energy production, as well as in the reduction of excessive proteins, damaged organelles, and membrane trafficking. It contributes to many human diseases, such as neurodegenerative diseases, carcinogenesis, diabetes mellitus, development, longevity, and reproduction. In this review, we provide important information for interpreting results related to autophagic experiments and present the role of autophagy in this field.


  • Open Access

    Inviting regulatory T cells to pregnant endometrium: friends or foes in adverse pregnancy outcomes?

    by Shibin Cheng, Zhengke Wang, Surendra Sharma

    Among decidual immune cells, regulatory T cells (Tregs) have been unanimously recognized as central contributors to tolerance and maintenance of healthy pregnancy. Numerical and functional downregulation of Tregs or disturbed interaction of Tregs with trophoblasts and other immune cells have been linked to early pregnancy loss such as idiopathic infertility and miscarriage and later-onset adverse pregnancy outcomes including preeclampsia. This review focuses on the mechanisms for regulating the generation, expansion, and function of Tregs, the roles of Tregs in maintaining maternal immune tolerance through crosstalk with trophoblasts and other decidual regulatory immune cells, and how Tregs may play foes to pregnancy and contribute to the programming of pregnancy-related complications. Therapeutic options for implantation failure and adverse pregnancy outcomes are now part of the emerging significance of Tregs in pregnancy tolerance and maintenance.


  • Open Access

    Hypoxia-Reoxygenation Impairs Autophagy-Lysosomal Machinery in Primary Human Trophoblasts Mimicking Placental Pathology of Early-Onset Preeclampsia

    by Shibin Cheng, Zheping Huang, Sukanta Jash, Kathleen Wu, Shigeru Saito, Akitoshi Nakashima, Surendra Sharma

    We have previously described that placental activation of autophagy is a central feature of normal pregnancy, whereas autophagy is impaired in preeclampsia (PE). Here, we show that hypoxia–reoxygenation (H/R) treatment dysregulates key molecules that maintain autophagy–lysosomal flux in primary human trophoblasts (PHTs). Ultrastructural analysis using transmission electron microscopy reveals a significant reduction in autophagosomes and autolysosomes in H/R-exposed PHTs. H/R-induced accumulation of protein aggregates follows a similar pattern that occurs in PHTs treated with a lysosomal disruptor, chloroquine. Importantly, the placenta from early-onset PE deliveries exhibits the same features as seen in H/R-treated PHTs. Taken together, our results indicate that H/R disrupts autophagic machinery in PHTs and that impaired autophagy in the placenta from early-onset PE deliveries mimics the events in H/R-treated PHTs. Notably, assessment of key regulators at each stage of autophagic processes, especially lysosomal integrity, and verification of autophagic ultrastructure are essential for an accurate evaluation of autophagy activity in human trophoblasts and placental tissue from PE deliveries.


  • Open Access

    The Autophagy-Lysosomal Machinery Enhances Cytotrophoblast–Syncytiotrophoblast Fusion Process

    by Atsushi Furuta, Tomoko Shima, Mihoko Kawaguchi, Akemi Yamaki-Ushijima, Ippei Yasuda, Sayaka Tsuda, Satoshi Yoneda, Kazuma Higashisaka, Shi-Bin Cheng, Kenji Matsumoto, et al.

    Poor placentation is closely related with the etiology of preeclampsia and may impact fetal growth restriction. For placental developmental growth, we have demonstrated that dysregulation of autophagy, a key mechanism to maintain cellular homeostasis, in trophoblasts contributes to the pathophysiology of preeclampsia, a severe pregnancy complication, associated with poor placentation. It remains, however, unknown whether autophagy inhibition affects trophoblast syncytialization. This study evaluated the effect of autophagy in an in vitro syncytialization method using BeWo cells and primary human trophoblasts (PHT). In this study, we observed that autophagic activity decreased in PHT and BeWo cells during syncytialization. This decreased activity was accompanied by downregulation of the transcription factor, TFEB. Next, bafilomycin A1, an inhibitor of autophagy via suppressing V-ATPase in lysosomes, inhibited hCG production, CYP11A1 expression (a marker of differentiation), p21 expression (a senescence marker), and cell fusion in BeWo cells and PHT cells. Finally, LLOMe, an agent inducing lysosomal damage, also inhibited syncytialization and led to TFEB downregulation. Taken together, the autophagy-lysosomal machinery plays an important role in cytotrophoblast fusion, resulting in syncytiotrophoblasts. As autophagy inhibition contributed to the failure of differentiation in cytotrophoblasts, this may result in the poor placentation observed in preeclampsia.